MedTrace Logo

Continuous Glucose Monitoring in Neonatal Hyperinsulinism

NCT06363929 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2025-10-01

No results posted yet for this study

Summary

The investigators are studying the accuracy of Dexcom G6 continuous glucose monitors placed on babies with hyperinsulinism in the Miller Children's Hospital Neonatal Intensive Care Unit. The participants will wear the device for 10 days on their lateral thigh. Whenever blood sugars are checked by glucometer, the investigators will also record the continuous glucose monitor sugar. Additionally, if the continuous glucose monitor alarms for a low sugar or an impending low sugar, the investigators will check the blood sugar by glucometer and, if verified to be low, treat the low blood sugar accordingly.

Conditions

  • Hyperinsulinism
  • Hypoglycemia Neonatal

Interventions

DEVICE

Dexcom G6 continuous glucose monitor

Dexcom G6 continuous glucose monitor to be placed on neonates with hyperinsulinism for 10 days.

Sponsors & Collaborators

  • DexCom, Inc.

    collaborator INDUSTRY

  • MemorialCare Health System

    lead OTHER

Principal Investigators

  • Erin L Okawa, MD · Memorial Health Services

Eligibility

Min Age
24 Hours
Max Age
3 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2025-09-22
Completion
2025-09-22
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06363929 on ClinicalTrials.gov